Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Induction of Regulatory t Cells by Low Dose IL2 in Autoimmune and Inflammatory Diseases: a Transnosographic Approach

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01988506
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:05.768309+00:00
Published At
2021-07-20T00:00:00+00:00
Record Updated At
2021-07-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Rheumatoid Arthritis", "Ankylosing Spondylitis", "Systemic Lupus Erythematosus", "Psoriasis", "Behcet\u0027s Disease", "Wegener\u0027s Granulomatosis", "Takayasu\u0027s Disease", "Crohn\u0027s Disease", "Ulcerative Colitis", "Autoimmune Hepatitis", "Sclerosing Cholangitis", "Gougerot-sj\u00f6gren", "Idiopathic Thrombocytopenic Purpura", "Systemic Sclerosis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-07-20"
protocolSection.identificationModule.nctId
"NCT01988506"
protocolSection.identificationModule.officialTitle
"Induction of Regulatory t Cells by Low Dose IL2 in Autoimmune and Inflammatory Diseases: a Transnosographic Approach"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Rheumatoid Arthritis (protocolSection.conditionsModule.conditions)
  • Ankylosing Spondylitis (protocolSection.conditionsModule.conditions)
  • Systemic Lupus Erythematosus (protocolSection.conditionsModule.conditions)
  • Psoriasis (protocolSection.conditionsModule.conditions)
  • Behcet's Disease (protocolSection.conditionsModule.conditions)
  • Wegener's Granulomatosis (protocolSection.conditionsModule.conditions)
  • Takayasu's Disease (protocolSection.conditionsModule.conditions)
  • Crohn's Disease (protocolSection.conditionsModule.conditions)
  • Ulcerative Colitis (protocolSection.conditionsModule.conditions)
  • Autoimmune Hepatitis (protocolSection.conditionsModule.conditions)
  • Sclerosing Cholangitis (protocolSection.conditionsModule.conditions)
  • Gougerot-sjögren (protocolSection.conditionsModule.conditions)
  • Idiopathic Thrombocytopenic Purpura (protocolSection.conditionsModule.conditions)
  • Systemic Sclerosis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.